Ocular Therapeutix (OCUL) Gross Margin Growth (1y) (2015 - 2026)
Ocular Therapeutix (OCUL) Gross Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 372.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -5.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -165.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 93.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocular Therapeutix | 1.91 Bn | 1.91 Bn | 9.46 Mn | -53.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.00 |
| Dec 31, 2025 | -483.00 |
| Sep 30, 2025 | -208.00 |
| Jun 30, 2025 | -527.00 |
| Mar 31, 2025 | -282.00 |
| Dec 31, 2024 | 216.00 |
| Sep 30, 2024 | -99.00 |
| Jun 30, 2024 | -59.00 |
| Mar 31, 2024 | 10.00 |
| Dec 31, 2023 | -217.00 |
| Sep 30, 2023 | -16.00 |
| Jun 30, 2023 | 83.00 |
| Mar 31, 2023 | 78.00 |
| Dec 31, 2022 | 181.00 |
| Sep 30, 2022 | 181.00 |
| Jun 30, 2022 | -6.00 |
| Mar 31, 2022 | 229.00 |
| Dec 31, 2021 | 25.00 |
| Sep 30, 2021 | -312.00 |
| Jun 30, 2021 | -81.00 |